Introduction
The vast majority of infections with Neisseria meningitidis (meningococcus) result in asymptomatic or mildly symptomatic pharyngeal carriage rather than invasive disease. Study of carriage is therefore essential to understand patterns of infection in diff erent epidemiological situations and to develop evidence-based strategies for vaccination. Data for vaccination strategies are particularly important because of the availability of proteinpolysaccharide conjugate vaccines, which, unlike plain polysaccharide vaccines, 1 are able to reduce carriage and thus transmission, generating herd protection. 2 Many cross-sectional studies of meningococcal carriage have been done in high-income countries, 3 but few studies have been undertaken of pathways of transmission. Meningococci are transmitted from the pharynx of one person to another via respiratory and throat secretions. Military studies have emphasised the importance of close personal contact in carriage acquisition. [3] [4] [5] [6] [7] In the UK, rapid acquisition of meningococcal carriage was reported in university students at the start of term and was associated with smoking, drinking, and intimate kissing. 4, 5 Carriage prevalence in contacts of people with meningococcal disease is higher than in the general population, 6 but we are aware of only two longitudinal household carriage studies done in highincome countries. 7, 8 Even less is known about the pattern of transmission of meningococcal infection in the African meningitis belt, where epidemics of meningococcal disease continue to occur. 9 In a 2007 Review 10 we showed that in several surveys, carriage peaked in older children and young adults. Subsequent large cross-sectional carriage surveys in Africa have shown carriage to be consistently highest in children aged 5-14 years, 11 with increased carriage rates in close contacts of people with the disease, suggesting that transmission within households is important. 12 The few longitudinal studies of carriage undertaken in the African meningitis belt have generally reported changes in trends over time at a population level rather than at the individual level, and thus were unable to estimate acquisition and the duration of carriage. [13] [14] [15] [16] [17] We are aware of only one previous study that has investigated patterns of transmission of meningococci within households in the African meningitis belt. 18 A 1976 study in northern Nigeria that took place over 11 months found that the duration of carriage was approximately 3 months for all meningococci and 1 month for serogroup A meningo cocci. Children younger than 10 years were identifi ed as fi rst carriers in a household signifi cantly more frequently than were adults, and men were more likely to introduce meningococci into a household than were women.
Because of the paucity of information on meningococcal carriage in the African meningitis belt, members of the African Meningococcal Carriage Consortium (MenAfriCar) 19 undertook a series of carriage surveys aiming to better understand patterns of meningococcal carriage and the impact of a new serogroup A meningococcal conjugate vaccine, MenAfriVac (Serum Institute of India PVT, Pune, India). 20 From Aug 1, 2010, to July 8, 2012, the consortium did 20 cross-sectional carriage surveys in seven African meningitis belt countries involving the collection of more than 48 000 pharyngeal swabs. 11 During these surveys, households in which a meningococcal carrier was identifi ed were recruited for a longitudinal study of household meningococcal trans mission; here we report the results of this longitudinal study.
Methods

Cross-sectional carriage surveys
The cross-sectional carriage surveys were conducted in seven countries in the African meningitis belt (Chad, Ethiopia, Ghana, Mali, Niger, Nigeria, and Senegal) in partnership with a national research institution, during the rainy season of 2010 (August to December), the rainy season of 2011 (July to November), and the dry season of 2012 (February to July). Details of the survey methods have been published previously. 19 The sampling frame used was either an updated, ongoing demographic surveillance system (DSS) in sites where a DSS existed or a household census undertaken specifi cally for the project. Study households were selected by simple random sampling from the DSS or census. Within selected households, individuals stratifi ed by age group (<1 years, 1-4 years, 5-14 years, 15-29 years, and 30 years or older) were randomly selected until the required sample size had been reached (surveys varied in target size from 2000-6000). Five surveys undertaken in Chad, Mali, and Niger were conducted after the introduction of vaccination with MenAfriVac in participants aged 1-29 years. The MenAfriCar studies were registered with ClinicalTrials.gov, number NCT01119482.
Household surveys
Longitudinal household surveys were triggered by the identifi cation of a putative carrier during a cross-sectional survey. Within 4 weeks of the identifi cation of a carrier, all members of the carrier's household were invited to participate in the follow-up study. Swabs (sterile, dacrontipped swabs with plastic shafts) of both the posterior pharynx and tonsils 21 were collected from all consenting members of the household at the fi rst visit and subsequently twice a month for 2 months and then monthly for a further 4 months up to a maximum of nine swabs per person. A questionnaire that asked about the characteristics of the household was administered to the head of the household and a detailed socioeconomic questionnaire was administered to individual parti cipants. Height and weight of each household contact older than 6 months of age were measured, and a pharyngeal swab and a 5 mL blood sample were obtained. On subsequent visits, pharyngeal swabs were taken and a short questionnaire was administered to obtain infor mation on risk factors, including MenAfriVac immunisation status, which might have changed since the last visit.
Identifi cation of a carrier at the study site depended upon conventional microbiology and serogrouping with an agglutination assay. 19 However, confi rmatory tests performed using molecular methods undertaken at the Department of Zoology at the University of Oxford (UK) resulted in some isolates being reclassifi ed as capsule-
Research in context
Evidence before this study We searched PubMed with the terms ([meningococcal OR Neisseria] AND [community OR household] AND carriage AND Africa) with no date or language restrictions up to Oct 21, 2015, and searched for early government reports from African meningitis belt countries in the personal archive of BG to identify longitudinal studies of meningococcal carriage in African households. Only one relevant study was identifi ed, which took place in 1976 in northern Nigeria over the course of 11 months. This study followed over 500 residents, estimating the duration of carriage to be around 3 months. Expanding our search to any location, we identifi ed only two further longitudinal household carriage studies, both from the USA.
Added value of this study
To our knowledge this is the fi rst multicentre and multicountry longitudinal meningococcal carriage study.
We address an important knowledge gap by describing the duration and acquisition of meningococci and patterns of transmission in households across the African meningitis belt.
Implications of all the available evidence
Results from this, and the previous study in Nigeria, show that the duration of meningococcal carriage is shorter in the African meningitis belt than in high-income countries. Within-household acquisition is important, with children aged 5-14 years being a common source of transmission, particularly to younger siblings. Chemoprophylaxis to household contacts of an individual with meningococcal disease, a public health intervention not widely used in Africa, should be emphasised as an additional meningitis prevention tool.
null organisms and others being not confi rmed as meningococci; thus some households were recruited in whom no meningococcal carrier was identifi ed on confi rmatory testing. These households formed a control group.
The study was approved by the ethics committee of the London School of Hygiene and Tropical Medicine and by the relevant authorities in each African country (appendix). The head of the household or another responsible adult gave verbal informed consent for the household to be included in the study. Each individual recruited within that household gave written informed consent (signature or thumbprint); a parent or guardian gave written consent for children younger than 18 years, with children older than 12 years additionally asked to give written assent.
Laboratory procedures
Pharyngeal swabs were plated directly onto modifi ed Thayer-Martin agar plates in the fi eld and taken to the laboratory within 6 h of collection where they were incubated for 24-48 h at 37°C in 5% CO 2 . Suspected N meningitidis colonies identifi ed on the plates were subcultured onto blood agar plates and tested using an oxidase test, followed by a Gram stain. All oxidasepositive, Gram-negative diplococci underwent biochemical testing and those identifi ed as N meningitidis on these tests underwent slide-agglutination sero grouping using antisera for serogroups A, W, X and Y, which we had identifi ed a priori as the likely most prevalent serogroups. All non-agglutinated strains were classifi ed as non-groupable (NG) by this method.
To confi rm the identity of Neisseria spp identifi ed by culture techniques, an aliquot of boiled suspensions of Gram-negative oxidase-positive bacteria was sent to the University of Oxford for molecular analysis as described previously. 19 Amplifi cation and sequencing of the rplF gene was used to confi rm the presence of, and to diff erentiate between, Neisseria spp. 22 Confi rmed N meningitidis were further characterised by genogroup (including capsule null [cnl] 23 ) and porA genotype.
Statistical analysis
There were few studies on the rate of meningococcal acquisition in household contacts in Africa to assist in the design of the household studies, but informed presumption was that the household acquisition rate would be around 1% per month. 18 We decided pragmatically that 25 households per survey in rural and urban areas would be the maximum number that the fi eld teams had the capacity to recruit and follow-up. Initially, restriction of recruitment to households of a serogroup A carrier was planned, but because of the paucity of carriers of this serogroup, 11 recruitment was expanded to include carriage of other capsulated meningococci.
Acquisition of carriage was initially defi ned as a newly identifi ed episode of carriage, preceded by at least one negative swab (appendix). We estimated the rates of carriage acquisition (λ) and loss (ν) using a two-state (infected and uninfected) hidden Markov model, implemented using the MSM package in R version 3.2.1. 24 We estimated the mean duration of carriage as 1/ν. The observations were assumed to be subject to misclassifi cation error and so we used the same statistical package to estimate sensitivity and specifi city of swabbing. We investigated covariates aff ecting transition intensities, including age, sex and whether an individual was from a household with at least one index carrier. We compared diff erent (nested) models with and without covariates using the likelihood ratio statistic. Data from individuals with only one swab through the course of the study were uninformative and thus we excluded these individuals from this analysis. We managed data using the TeleForm system version 10 Cambridge UK), 19 with a separate database module to link the main study database with genetic laboratory results from the Oxford Bacterial Isolate Genome Sequence (BIGS) database. 25 We used Stata version 12.0 for data cleaning and descriptive analyses.
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
218 households were recruited to the study (fi gure 1). 1351 individuals from 184 households participated in the study (appendix); no data were available for Nigeria. 633 individuals (47%) reported that they had not received a meningitis vaccine in the last 3 years, 502 (37%) reported that they had recently been vaccinated (224 of whom were vaccinated again during the study), and 216 (16%) individuals reported being new vaccine recipients during the course of the study. Most reports of previous vaccination (89%) were recorded in Chad, Mali, and Niger, where mass vaccination with MenAfriVac in participants aged 1-29 years was being undertaken at the time of the follow-up study. 133 (72%) of the 184 households had a confi rmed index carrier at visit 0 or visit 1 or both (980 people in household), leaving 51 (28%) households (of 371 people) in which the initial report of isolation of N meningitidis was not confi rmed on molecular analysis (table 1); these households formed the control group that was used to study external acquisitions. 241 (25%) individuals in the 133 households were index carriers (carrier at visit 0 or 1). 60 households contained more than one index carrier (range one to eight carriers per household). The median age of index carriers was 12 years (IQR 8-23 years) and 133 (55%) were male. cnl was the most common genogroup identifi ed, followed by genogroup W (fi gure 2). 69 individuals were carriers at both the cross-sectional recruitment visit (visit 0) and fi rst household visit (visit 1). Among these, 56 (81%) carried strains with the same genogroup and porA alleles at both visits, and only three (4%) carried defi nitively diff erent strains between visit 0 and visit 1.
During the course of the 6 month follow-up period, 9809 swabs were obtained from the 1351 participants; 63% individuals provided eight or nine swabs and 86% of individuals provided at least fi ve swabs. The median number of swabs obtained per participant was eight (IQR seven to nine). This number was similar in households with and without an index carrier. The median duration of follow-up from fi rst to last swab was 6·1 months (IQR 5·2-6·6). None of the participants who Among the 371 people in 51 households without an index carrier, 35 (9%) people in 17 households became a carrier during the course of the study. 25 individuals were identifi ed as the fi rst carrier in these households (ie, the person introducing the strain into the household), of whom 15 (60%) were female and ten (40%) male; three (12%) individuals were younger than 5 years, 13 (52%) aged 5-14 years, six (24%) aged 15-29 years, and three (12%) aged 30 years and older.
The overall acquisition rate and duration of carriage, together with mis classi fi cation probabilities, were estimated using a hidden Markov model. The best fi tting model was one that included age group and household index status as covariates. The overall estimated acquisition rate of carriage in this model was 2·4% per month (95% CI 1·6-4·0; table 2). Acquisition rates were highest in the youngest children and lowest among older adults (table 2) . Acquisition rates were estimated to be between four-times and fi ve-times higher in each age group among households with an index carrier than in those without an index carrier. The estimated mean duration of carriage was 3·4 months overall (95% CI 2·7-4·4) and was lowest in children under 5 years of age (table 2) .
Only 20 individuals had a positive swab on six or more occasions: six individuals with group W, six with cnl, four with group Y, one with group B, and three mixed carriers. The estimated duration of carriage in these 20 individuals was 5·8 months (assuming that a single negative swab bordered by positive swabs was a false negative).
The specifi city of swabbing in the full dataset was estimated to be very high at 99·2% (95% CI 98·5-99·6), whereas the sensitivity of swabbing was estimated to be much lower at 57·8% (53·5-62·0).
Data were analysed further according to the strain type (genogroup and porA) of meningococci within the household. Among the 75 households with both an index carrier and later acquisitions, the index strain was acquired by another household member in 52 households, and a similar strain (with incomplete typing) was acquired in a further fi ve households. Where direct family relationships could be elucidated in these transmission events, sibling to sibling transmission was most common (27 events), followed by child to parent (ten) and then parent to child (six). In the subset of these events where the subsequent carrier was a young child (aged <4 years), most children appeared to have acquired carriage from a sibling (13 of 16 events) rather than a parent (three of 16 events). In 39 households, a completely diff erent strain to the index carrier was acquired by a subsequent carrier.
There was insuffi cient power to examine the eff ect of MenAfriVac on acquisition or loss of group A carriage because few group A carriers were identifi ed during the cross-sectional studies. 11 However, 11 individuals identifi ed as group A carriers were vaccinated during the course of follow-up and no further group A carriage was detected after vaccination (fi gure 3).
Discussion
In 184 households across the African meningitis belt, the overall rate of acquisition of meningococci was 2·4% per month. Within household transmission was important, especially among children aged less than 5 years, who were the group most likely to acquire carriage from other household members. However, acquisition of carriage outside the household was evident from detection of new carriers within households without an index carrier and from examination of strain types. The average duration of carriage was 3·4 months, shorter than is usually found in Europe, 21 and persistent carriers were uncommon. Few previous studies have examined the patterns of household transmission of meningococci with which our fi ndings can be compared. The strengths of this study are that it was conducted in six countries across the African meningitis belt, involved both urban and rural populations, included participants across the age spectrum, achieved a high follow-up rate, and used standardised fi eld and laboratory protocols. Thus, the fi ndings are likely to be representative of the pattern of transmission of N meningitidis across the African meningitis belt. However, it should be noted that the households recruited were not evenly balanced between countries and survey periods (table 1) .
Although common protocols and microbiological methods were used across the diff erent study sites, and characterisation of Neisseria spp was confi rmed in Oxford using DNA samples, there might have been some diff erences between laboratories in their ability to detect oxidase-positive Gram-negative diplococci. Additionally we assumed that carriage of the same strain as the index case represented within-household transmission but we cannot rule out external acquisition as the strain type might also have been circulating in the wider community. We also assumed that a newly identifi ed episode of carriage represented acquisition. Due to the infrequent detection of group A carriage we were unable to determine the relative eff ects of vaccination on reducing the duration of carriage compared with preventing acquisition. 26 There was heterogeneity in carriage duration, with some long-term carriers identifi ed. Index carriers in our study might have been biased towards having longer durations because these individuals would be more likely to be detected in a cross-sectional study than those with shorter duration of carriers; we were not able to adjust for this in our statistical model.
We have reported previously that the prevalence of carriage detected during cross-sectional surveys in African meningitis belt countries is generally lower than in highincome countries. 11 Although this might refl ect a lower incidence of infection (perhaps predisposing to epidemics), the short duration of carriage identifi ed in this study, and in the only other previous study of carriage duration in Africa, 18 will also aff ect prevalence. Why the duration of carriage would be less in the African meningitis belt than in high-income countries is uncertain. This fi nding could be a refl ection of a higher background level of immunity, although this hypothesis would not fi t with a predisposition to epidemics. An alternative explanation is inhibition by other bacteria present in the nasopharynx, and it is of note that the shortest duration of carriage in the MenAfriCar consortium study was in children younger than 5 years among whom carriage of N lactamica was highest. 27, 28 N lactamica has recently been shown to inhibit colonisation with N meningitidis in young adults. 29 Another striking diff erence in carriage is that there is a similar prevalence in children and young adults in Africa 11 compared with marked peaks in older teenagers and adults in highincome countries. 3 Widespread deployment of MenAfriVac has, so far, proved highly successful in suppressing outbreaks of epidemics caused by serogroup A meningococci. However, outbreaks due to other serogroups continue to occur, with the most recent example being the 2015 epidemic of serogroup C disease in Niger. 9 Until an aff ordable multivalent vaccine is available, other control measures will be needed. Our fi ndings indicate that substantial spread of meningococci occurs within households so that prophylaxis of household contacts after a case of meningococcal meningitis, recommended policy in the meningitis belt outside epidemics, 30 could be given greater priority. However, given that acquisition of infection from outside of the household also occurs, vaccination of the whole population of aff ected communities will be needed to prevent transmission completely and the fi ndings from this study will help to guide decisions on the age groups who should be given priority.
